AJCN Yamada Bee Farm Grant for Honeybee Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FitzGerald, G. A.
Right arrow Articles by Barry, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FitzGerald, G. A.
Right arrow Articles by Barry, P.
Agricola
Right arrow Articles by FitzGerald, G. A.
Right arrow Articles by Barry, P.

American Journal of Clinical Nutrition, Vol 65, 1699S-1701S, Copyright © 1997 by The American Society for Clinical Nutrition, Inc


REVIEW ARTICLES

Dietary factors in thrombosis and hemostasis: summary and conclusions

GA FitzGerald and P Barry
Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia 19104, USA. garret@spirit.gcrc.upenn.edu

Patients who develop thrombotic vascular occlusions usually have underlying vascular disease. However, the interplay among lipids, atherogenesis, and thrombosis has proven difficult to define in humans. The evidence for a contribution from individual dietary lipids to thrombogenesis was reviewed in the preceding section of this supplement. Although feeding long-chain fatty acids in animal models may increase the propensity to thrombosis in animal models, the implications of this observation for human diets are obscure. This may reflect the multiple pro- and anticoagulant species that may be regulated by dietary constituents. The role of lipids in the regulation of gene expression is emerging; however, it is unknown what relevance such observations may have for dietary lipids. The study of thrombosis in vivo and, particularly, investigations of the propensity to thrombosis is confounded in many cases by ex vivo platelet activation. Evidence for a prothrombotic state is still controversial. Even the association of elevated fibrinogen with the incidence of coronary disease may not reflect a causative mechanism. Limited information is available as to health benefits of individual lipids, although drugs that lower cholesterol unequivocally reduce the incidence of cardiovascular death, even in patients with moderate hypercholesterolemia.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The American Society for Nutrition